William Slayton, MD : Research

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other…

Investigators

William Slayton, Brian Stover

Status

Accepting Candidates

Ages

3 Years - 29 Years

Sexes

All

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after…

Investigators

William Slayton, Brian Stover

Status

Accepting Candidates

Ages

N/A - 22 Years

Sexes

All

The addition of targeted immunotherapy will be safe and well tolerated and facilitate the reduction of anthracycline exposure while preserving lymphoma disease control in children, adolescents and young adults (CAYA) with mature B-cell non-Hodgkin…

Investigators

William Slayton, Jordan Milner

Status

Accepting Candidates

Ages

3 Years - 39 Years

Sexes

All